RMR Wealth Builders’s FibroBiologics FBLG Stock Holding History

RMR Wealth Builders’s Portfolio FBLG Stock Details FBLG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,918	Closed	-$8.63K	–	295
2025 Q4	$8.63K	Hold	1,918	–	–	﹤0.01%	275
2025 Q3	$21K	Hold	1,918	–	–	﹤0.01%	282
2025 Q2	$23.9K	Hold	1,918	–	–	﹤0.01%	285
2025 Q1	$34.5K	Hold	1,918	–	–	﹤0.01%	259
2024 Q4	$76.7K	Buy	1,918 +5	+0.3%	+$268	0.01%	254
2024 Q3	$118K	Buy	1,913 +45	+2%	+$2.99K	0.01%	257
2024 Q2	$186K	Buy	+1,868	New	+$356K	0.02%	243

Other funds holding FBLG

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FEG

Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CFP

Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Vanguard Global Advisers Malvern, Pennsylvania $215B AUM

RMR Wealth Builders's FBLG Position: Q1 2026 in Review

RMR Wealth Builders sold out of FibroBiologics (FBLG) in Q1 2026, closing a stake of 1,918 shares — an estimated $8.63K sold.

RMR Wealth Builders first reported a position in FBLG in Q2 2024 and held it in 7 quarters. The position peaked at $186K in Q2 2024. 17 funds tracked by Wall St. Rank hold FBLG as of Q1 2026.

RMR Wealth Builders reported no remaining FibroBiologics position as of Q1 2026 after selling out during the quarter.
RMR Wealth Builders sold 1,918 FibroBiologics shares in Q1 2026, an estimated $8.63K.
RMR Wealth Builders first reported a position in FibroBiologics in Q2 2024 and held it in 7 quarters.
RMR Wealth Builders's FibroBiologics position peaked at $186K in Q2 2024.
17 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2026.

Based on RMR Wealth Builders's 13F filing for Q1 2026, filed 22 Apr 2026.